ACTIVE SUBSTANCE / INN

MEMANTINE HYDROCHLORIDE

Brand name(s): NAMENDA XR, NAMZARIC, NAMENDA, MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE, Memantine Merz, MEMANTINE HYDROCHLORIDE
FDA LISTED
EMA LISTED
PRESCRIPTION
DISCONTINUED
AUTHORISED
ANDA216901
NDA021627
ACTIVE SUBSTANCE
Memantine Hydrochloride
REGULATORS
FDA · EMA
SPONSORS / MAH
Merz Pharmaceuticals GmbH  , ABBVIE, ALLERGAN
TOTAL APPLICATIONS
9
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
MEMANTINE HYDROCHLORIDEANDA202790MACLEODS PHARMS LTDPrescription
MEMANTINE HYDROCHLORIDEANDA205446SCIEGEN PHARMSDiscontinued
MEMANTINE HYDROCHLORIDEANDA214731NOVAST LABS LTDNone (Tentative Approval)
NAMENDANDA021487ABBVIEPrescription
NAMENDA XRNDA022525ABBVIEDiscontinued
NAMZARICNDA206439ABBVIEPrescription
MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDEANDA216901XIAMEN LP PHARM COPrescription
NAMENDANDA021627ALLERGANDiscontinued
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
Memantine MerzMerz Pharmaceuticals GmbH  Authorised22/11/2012Alzheimer Disease

FULL INTELLIGENCE ON MEMANTINE HYDROCHLORIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →